Skip to main content

Table 1 Patient characteristics

From: Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients with primary central nervous system diffuse large B-cell lymphoma

 

All patients

(n = 68)

Low sPD-L1

(n = 36)

High sPD-L1

(n = 32)

 
 

n

(%)

n

(%)

n

(%)

P

Age (years)

  ≤ 60

41

(60)

22

(61)

19

(59)

0.884

  >  60

27

(40)

14

(39)

13

(41)

 

Sex

 Male

27

(40)

13

(36)

14

(44)

0.622

 Female

41

(60)

23

(64)

18

(56)

 

ECOG PS

 0–1

56

(82)

33

(92)

23

(72)

0.054

  ≥ 2

12

(18)

3

(8)

9

(28)

 

Serum Lactate dehydrogenase

 Normal

54

(79)

29

(81)

25

(78)

>  0.999

 Elevated

14

(21)

7

(19)

7

(22)

 

Number of lesions

 Single

11

(16)

7

(19)

4

(12)

0.521

 Multiple

57

(84)

29

(81)

28

(88)

 

Brain deep region involvement

 Absence

44

(65)

23

(64)

21

(66)

>  0.999

 Presence

24

(35)

13

(36)

11

(34)

 

Cell of origin subtype

 GCB

13

(19)

8

(22)

5

(16)

0.719

 ABC

50

(74)

25

(69)

25

(78)

 

 Not evaluated

5

(7)

3

(8)

2

(6)

 

Ki67

  < 90

23

(34)

11

(31)

12

(38)

0.769

  ≥ 90

42

(62)

23

(64)

19

(59)

 

 Not evaluated

3

(4)

2

(6)

1

(3)

Â